Back
ESC Premium Access

Panel discussion

Session: Discussing the opportunities for SGLT2 in clinical cardiology
Topic: Risk Factors and Prevention, Other
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor T. Luescher (London, GB) Professor C. Wanner (Wuerzburg, DE) Professor J. Deanfield (London, GB)
Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speakers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
108 presentations
8 followers

Professor Thomas Felix Luescher

Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
75 presentations
16 followers

Professor Christoph Wanner

University Hospital Wuerzburg, Wuerzburg (Germany)
10 presentations
1 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
57 presentations
6 followers

2 more presentations in this session

Introduction

Speaker: Professor T. Luescher (London, GB)

Access
Slides
Video
Like
Thumbnail

Summary - The expanding role of SGLT2i in cardiovascular risk, kidney disease and heart failure .

Speaker: Professor C. Wanner (Wuerzburg, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access
Like
Thumbnail

Access the full session

Discussing the opportunities for SGLT2 in clinical cardiology

Speakers: Professor F. Zannad, Professor T. Luescher, Professor C. Wanner, Professor J. Deanfield, Professor T. Luescher...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources